Autologous blood cell transplantation versus HLA-identical siblingtransplantation for acute myeloid leukemia in first complete remission:a registry study from the Center for International Blood and MarrowTransplantation Research.
Haematologica., Sep (2012)
Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
J. Clin. Oncol., Aug;30(22):2753-9 (2012)
Outcomes after induction failure in childhood acute lymphoblastic leukemia.
N. Engl. J. Med., Apr;366(15):1371-81 (2012)
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
J. Clin. Oncol., May;30(14):1663-9 (2012)
Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.
Biol. Blood Marrow Transplant., Aug;18(8):1204-10 (2012)
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.
Blood., Apr;119(15):3512-22 (2012)
Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ ALL: a Children's Oncology Group (COG) study.
Br. J. Haematol., May;157(4):507-10 (2012)
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
J. Clin. Oncol., Mar;30(7):751-7 (2012)
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
J. Pediatr. Hematol. Oncol., Dec;33(8):610-6 (2011)
Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.
Biol. Blood Marrow Transplant., Feb;18(2):280-8 (2012)
Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH.
Pediatr Blood Cancer., Jul;59(1):189-90 (2012)
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood., Sep;118(11):3080-7 (2011)
Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).
Blood., Jul;118(4):874-83 (2011)
Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung.
J. Pediatr. Hematol. Oncol., Apr;33(3):e127-31 (2011)
Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.
J. Pediatr. Hematol. Oncol., Jan;34(1):e1-7 (2012)
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
Pediatr Blood Cancer., Oct;57(4):569-77 (2011)
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.
Nat. Genet., Mar;43(3):237-41 (2011)
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
J. Clin. Oncol., Aug;28(23):3730-8 (2010)
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.
Blood., Aug;116(7):1045-50 (2010)
Absidia corymbifera endocarditis: survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall.
J. Thorac. Cardiovasc. Surg., Apr;139(4):e71-2 (2010)